Creative and Actionable Solutions to Complex Strategic Issues Facing Leaders in the Life Science Industry

 
 
Case Studies
We just completed a global strategic planning exercise, and our mandate is to enter a specific strategic space. Can you help?
We just completed a global strategic planning exercise, and our mandate is to enter a specific strategic space. Can you help?
Read More →
As a Fortune 100 company, our corporate venture arm invests in later stage deals. However, we also need to invest in early discovery from academia and early startups. How can we extend our reach?
As a Fortune 100 company, our corporate venture arm invests in later stage deals. However, we also need to invest in early discovery from academia and early startups. How can we extend our reach?
Read More →
We hear a great deal about digital health and home monitoring technologies. How do we best position ourselves to take advantage of this growing area?
We hear a great deal about digital health and home monitoring technologies. How do we best position ourselves to take advantage of this growing area?
Read More →
We have a late stage product in clinical trials; what is the full extent of the commercial opportunity? What is a viable commercialization strategy?
We have a late stage product in clinical trials; what is the full extent of the commercial opportunity? What is a viable commercialization strategy?
Read More →
As a European developer of technology; it’s clear that the US is our key market; how do we penetrate the largest healthcare market in the world?
As a European developer of technology; it’s clear that the US is our key market; how do we penetrate the largest healthcare market in the world?
Read More →
We have developed a new cancer screening technology that could save lives – will the clinical community adopt it?
We have developed a new cancer screening technology that could save lives – will the clinical community adopt it?
Read More →
Convergence of two disparate fields – what are the FDA regulatory implications? What about the key reimbursement issues?
Convergence of two disparate fields – what are the FDA regulatory implications? What about the key reimbursement issues?
Read More →
Nanotechnology: an opportunity or a threat?
Nanotechnology: an opportunity or a threat?
Read More →
Our researchers keep submitting invention disclosures – where do we allocate our scarce resources for IP development?
Our researchers keep submitting invention disclosures – where do we allocate our scarce resources for IP development?
Read More →
Just spun out a novel technology and we have patent rights – how do we build a business around this technology?
Just spun out a novel technology and we have patent rights – how do we build a business around this technology?
Read More →
We’ve identified a key strategic investment opportunity that is highly sought after – how do we compete with other investors to have a key seat at the table?
We’ve identified a key strategic investment opportunity that is highly sought after – how do we compete with other investors to have a key seat at the table?
Read More →
We want to invest in healthcare, but what are the right investment opportunities to target to create a risk-balanced investment portfolio?
We want to invest in healthcare, but what are the right investment opportunities to target to create a risk-balanced investment portfolio?
Read More →